A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...

Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy ...

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...

Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of ...

Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...

TransMedics Group remains a Strong Buy, driven by robust revenue growth, expanding organ platforms, and strategic international initiatives. Learn more about TMDX stock here.

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...

The company is focused on completing enrollment in its Phase 3 IFx-2.0 study with Keytruda for advanced Merkel cell carcinoma ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the ...

The Department of Health and Human Services (HHS) will invest $100 million to improve homelessness, opioid addiction and ...

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...

Medical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with ...